Journal
CELL METABOLISM
Volume 6, Issue 6, Pages 458-471Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2007.11.001
Keywords
-
Categories
Funding
- NIAMS NIH HHS [R01 AR055255, R01 AR055027, R01 AR055027-17, R01 AR055255-02] Funding Source: Medline
- NINDS NIH HHS [NS27963] Funding Source: Medline
- Telethon [TCP04009] Funding Source: Medline
Ask authors/readers for more resources
Autophagy allows cell survival during starvation through the bulk degradation of proteins and organelles by lysosomal enzymes. However, the mechanisms responsible for the induction and regulation of the autophagy program are poorly understood. Here we show that the FoxO3 transcription factor, which plays a critical role in muscle atrophy, is necessary and sufficient for the induction of autophagy in skeletal muscle in vivo. Akt/PKB activation blocks FoxO3 activation and autophagy, and this effect is not prevented by rapamycin. FoxO3 controls the transcription of autophagy-related genes, including LC3 and Bnip3, and Bnip3 appears to mediate the effect of FoxO3 on autophagy. This effect is not prevented by proteasome inhibitors. Thus, FoxO3 controls the two major systems of protein breakdown in skeletal muscle, the ubiquitin-proteasomal and autophagic/lysosomal pathways, independently. These findings point to FoxO3 and Bnip3 as potential therapeutic targets in muscle wasting disorders and other degenerative and neoplastic diseases in which autophagy is involved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available